HCAT - Health Catalyst - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HCAT is currently covered by 8 analysts with an average price target of $2.31. This is a potential upside of $0.56 (32%) from yesterday's end of day stock price of $1.75.

Health Catalyst's activity chart (see below) currently has 258 price targets and 221 ratings on display. The stock rating distribution of HCAT is 70% HOLD and 30% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.17% with an average time for these price targets to be met of 92.21 days.

Highest price target for HCAT is $4, Lowest price target is $1.5, average price target is $2.31.

Most recent stock forecast was given by RICHARD CLOSE from CANACCORD on 21-Aug-2026. First documented stock forecast 19-Aug-2019.

Currently out of the existing stock ratings of HCAT, 14 are a HOLD (70%), 6 are a BUY (30%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Apr-2020

$1.8

$0.05 (2.86%)

1 months 12 days ago
(21-Aug-2026)

6/15 (40%)

$0.27 (17.65%)

75

Hold Since 26-Jun-2026

$1.5

$-0.25 (-14.29%)

$1.75

1 months 20 days ago
(13-Aug-2026)

3/11 (27.27%)

$-0.25 (-14.29%)

20

Hold Since 11-Nov-2025

$2

$0.25 (14.29%)

$1.75

1 months 22 days ago
(11-Aug-2026)

6/19 (31.58%)

$0.24 (13.64%)

181

Hold Since 08-Aug-2024

$1.75

$-0.15 (-7.89%)

$2

4 months 20 days ago
(12-May-2026)

3/6 (50%)

$0.27 (18.24%)

14

Hold Since 09-Sep-2025

$3

4 months 21 days ago
(11-May-2026)

0/11 (0%)

$1.68 (127.27%)

Show more analysts

Please expand the browser size to see the chart

What is HCAT (Health Catalyst) average time for price targets to be met?

On average it took 92 days for the stock forecasts to be reached, with an average price target met ratio of 33.17%.

Which analyst most recently updated their price target on HCAT (Health Catalyst)?

Richard Close

Which analyst has the most public recommendations on HCAT (Health Catalyst)?

Richard Close works at CANACCORD and has 4 price targets and 0 ratings on HCAT

Which analyst is the currently most bullish on HCAT (Health Catalyst)?

Robert Jones with the highest potential upside of $58.25

Which analyst is the currently most reserved on HCAT (Health Catalyst)?

Stan Berenshteyn with the lowest potential downside of -$0.25
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?